CDKN2A and acute lymphoblastic leukemia: Optical Genome Mapping (OGM) enables high-resolution detection of structural genomic alterations with established prognostic significance in acute lymphoblastic leukemia (ALL), including deletions affecting CDKN2A/B, IKZF1, and PAX5 loci.